A significant proportion of breast and/or ovarian cancer families of French Canadian descent harbour specific recurrent mutations in BRCA1 and BRCA2 [1] which confer a significantly increased lifetime risk of developing young age of onset breast cancer and ovarian cancer [2-5]. This evidence concerns the gene BRCA2 and breast carcinoma.